These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 15547786

  • 1. Involvement of the sigma1 receptor in the appetitive effects of cocaine.
    Maurice T, Romieu P.
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S198-207. PubMed ID: 15547786
    [Abstract] [Full Text] [Related]

  • 2. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M, Delair B, Foulon C, Lempereur N, Vaccher C, Maurice T, Melnyk P.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):504-15. PubMed ID: 19249191
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward.
    Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F.
    Neuropsychopharmacology; 2007 Sep; 32(9):1967-73. PubMed ID: 17268407
    [Abstract] [Full Text] [Related]

  • 4. Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies.
    Liu Y, Matsumoto RR.
    J Pharmacol Exp Ther; 2008 Oct; 327(1):187-95. PubMed ID: 18591217
    [Abstract] [Full Text] [Related]

  • 5. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G.
    Pol J Pharmacol; 1999 Oct; 51(6):477-83. PubMed ID: 10817525
    [Abstract] [Full Text] [Related]

  • 6. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade.
    Romieu P, Phan VL, Martin-Fardon R, Maurice T.
    Neuropsychopharmacology; 2002 Apr; 26(4):444-55. PubMed ID: 11927169
    [Abstract] [Full Text] [Related]

  • 7. Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction.
    Fritz M, Klement S, El Rawas R, Saria A, Zernig G.
    Pharmacology; 2011 Apr; 87(1-2):45-8. PubMed ID: 21196793
    [Abstract] [Full Text] [Related]

  • 8. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
    Thompson BE, Sachs BD, Kantak KM, Cherry JA.
    Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
    [Abstract] [Full Text] [Related]

  • 9. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
    Koeltzow TE, Vezina P.
    Behav Brain Res; 2005 May 28; 160(2):250-9. PubMed ID: 15863221
    [Abstract] [Full Text] [Related]

  • 10. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR.
    Neuropharmacology; 2005 Oct 28; 49(5):638-45. PubMed ID: 15939443
    [Abstract] [Full Text] [Related]

  • 11. Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice.
    Maldonado C, Rodríguez-Arias M, Castillo A, Aguilar MA, Miñarro J.
    Behav Pharmacol; 2006 Mar 28; 17(2):119-31. PubMed ID: 16495720
    [Abstract] [Full Text] [Related]

  • 12. sigma Receptor antagonists block the development of sensitization to cocaine.
    Ujike H, Kuroda S, Otsuki S.
    Eur J Pharmacol; 1996 Jan 25; 296(2):123-8. PubMed ID: 8838447
    [Abstract] [Full Text] [Related]

  • 13. Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference.
    Maldonado C, Rodríguez-Arias M, Castillo A, Aguilar MA, Miñarro J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):932-9. PubMed ID: 17395352
    [Abstract] [Full Text] [Related]

  • 14. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
    Fukushiro DF, Alvarez Jdo N, Tatsu JA, de Castro JP, Chinen CC, Frussa-Filho R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):867-72. PubMed ID: 17368685
    [Abstract] [Full Text] [Related]

  • 15. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
    Velázquez-Sánchez C, Ferragud A, Hernández-Rabaza V, Nácher A, Merino V, Cardá M, Murga J, Canales JJ.
    Neuropsychopharmacology; 2009 Nov 09; 34(12):2497-507. PubMed ID: 19606084
    [Abstract] [Full Text] [Related]

  • 16. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 17. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S, Funk D, Lê AD.
    Neurosci Lett; 2005 Aug 05; 383(3):209-14. PubMed ID: 15955413
    [Abstract] [Full Text] [Related]

  • 18. Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference.
    Bahi A, Kusnecov AW, Dreyer JL.
    Behav Brain Res; 2008 Aug 05; 191(1):17-25. PubMed ID: 18436315
    [Abstract] [Full Text] [Related]

  • 19. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
    Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP.
    Brain Res; 2005 Feb 09; 1034(1-2):162-71. PubMed ID: 15713268
    [Abstract] [Full Text] [Related]

  • 20. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
    Dhir A, Kulkarni SK.
    Fundam Clin Pharmacol; 2008 Aug 09; 22(4):387-94. PubMed ID: 18705749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.